NeoGenomics, Inc. Net Fee Amt
NeoGenomics, Inc. (NEO) had Net Fee Amt of $11.50 thousand as of 2026-08-25, per its S-8 filed 2026-08-25.
Financial Statements › Notes
ffd:NetFeeAmt · last filed 2026-08-25
- 2026-08-25: Net Fee Amt $11.50K.
| Period end | Net Fee Amt |
|---|---|
| 2026-08-25 | $11.50K S-8 · filed 2026-08-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |